608184887	608184887	CD	B-NP	O
|	|	NN	I-NP	O
FMMH	FMMH	NN	I-NP	O
|	|	NN	I-NP	O
81286632	81286632	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0872888	0872888	CD	B-NP	O
|	|	CC	I-NP	O
2/14/2006	2/14/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/27/2006	3/27/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/27/2006	10/27/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
RINGWOOD	RINGWOOD	NN	B-NP	O
,	,	,	O	O
JESSIE	JESSIE	NN	B-NP	O
914-41-72-8	914-41-72-8	CD	I-NP	O
Connecticut	Connecticut	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/26/06	7/26/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
UMALI	UMALI	NNP	B-NP	O
,	,	,	O	O
DARREN	DARREN	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	B-protein
81	81	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/30	2/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/30	2/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/1/06	1/1/06	CD	B-NP	O
by	by	IN	B-PP	O
LISTA	LISTA	NNP	B-NP	O
,	,	,	O	O
DONNY	DONNY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
906633512	906633512	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/1/06	1/1/06	CD	B-NP	O
by	by	IN	B-PP	O
PRASAD	PRASAD	NNP	B-NP	O
,	,	,	O	O
NORMAND	NORMAND	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
508385930	508385930	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/30	2/30	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
PLAVIX	PLAVIX	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Tomorrow	Tomorrow	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
2/13	2/13	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
until	until	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
stop	stop	VB	I-VP	O
taking	take	VBG	I-VP	O
it	it	PRP	B-NP	O
LANTUS	LANTUS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/30	2/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
give	give	VB	B-VP	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
when	when	WRB	B-ADVP	O
npo	npo	NN	B-NP	B-protein
HUMALOG	HUMALOG	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
LISPRO	LISPRO	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
15	15	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
AC	AC	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
not	not	RB	O	O
taking	take	VBG	B-VP	O
anything	anything	NN	B-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
640	640	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
771-2390	771-2390	CD	I-NP	O
1/4/06	1/4/06	CD	I-NP	O
@	@	NN	I-NP	O
9	9	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
AM	AM	NNP	I-NP	O
,	,	,	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
at	at	IN	B-PP	O
Fra	Fra	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
680-778-0899	680-778-0899	CD	B-NP	O
vpm	vpm	NN	I-NP	O
.	.	.	O	O

79384	79384	CD	B-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
or	or	CC	I-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
+	+	SYM	I-NP	O
L	L	NN	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
9/29/02	9/29/02	CD	B-NP	O
.	.	.	O	O

PCI	PCI	NN	B-NP	B-protein
+	+	SYM	I-NP	O
Cypher	Cypher	NNP	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NONE	NONE	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
SOB	SOB	NN	B-NP	B-protein
************************	************************	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
49	49	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
spotty	spotty	JJ	B-NP	O
med	me	VBN	I-NP	O
compliance	compliance	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
and	and	CC	O	O
``	``	``	B-VP	O
burning	burn	VBG	I-VP	O
''	''	''	B-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
which	which	WDT	B-NP	O
became	become	VBD	B-VP	O
acutely	acutely	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
four	four	CD	B-NP	O
blocks	block	NNS	I-NP	O
.	.	.	O	O

Symptoms	Symptom	NNS	B-NP	O
improved	improve	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
rest	rest	NN	I-NP	O
,	,	,	O	O
worsened	worsen	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Denied	Deny	VBN	B-NP	O
associated	associate	VBN	I-NP	O
nausea/diaphoresis	nausea/diaphoresis	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
pt	pt	NN	B-NP	O
reclined	recline	VBN	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
sxs	sx	NNS	B-NP	O
became	become	VBD	B-VP	O
acutely	acutely	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
-LRB-	-LRB-	NN	B-NP	B-protein
both	both	CC	O	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
burning	burn	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
;	;	:	O	O
these	these	DT	B-NP	O
improved	improve	VBN	B-VP	O
immediately	immediately	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
sat	sit	VBD	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Typically	Typically	RB	B-ADVP	O
uses	use	VBZ	B-VP	O
2	2	CD	B-NP	O
pillows	pillow	NNS	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
PND	PND	NN	B-NP	B-protein
.	.	.	O	O

Has	Have	VBD	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
lisinopril	lisinopril	NN	B-NP	O
or	or	CC	I-NP	O
lipitor	lipitor	NN	I-NP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	O
week	week	NN	I-NP	O
b/c	b/c	NN	I-NP	O
ran	run	VBD	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
meds	med	NNS	B-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
+	+	SYM	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
occ	occ	NN	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
N/V/diarrhea	N/V/diarrhea	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	B-cell_line
HR	HR	NN	I-NP	I-cell_line
91	91	CD	I-NP	I-cell_line
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
186/99	186/99	CD	I-NP	I-DNA
,	,	,	O	O
SpO2	SpO2	NN	B-NP	O
87	87	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
4L	4L	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
rales	rale	VBZ	B-VP	O
3/4	3/4	CD	B-NP	O
way	way	NN	I-NP	O
up	up	IN	B-ADVP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
40mg	40mg	CD	B-NP	O
IV	IV	CD	I-NP	O
lasix	lasix	CD	I-NP	O
given	give	VBN	B-VP	O
--	--	:	O	O
>	>	SYM	O	O
900	900	CD	B-NP	O
cc	cc	NN	I-NP	O
UOP	UOP	NN	I-NP	O
,	,	,	O	O
RA	RA	NN	B-NP	O
sat	sit	VBD	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

************************	************************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
DIABETES	DIABETES	NNS	B-NP	O
,	,	,	O	O
INS	INS	NNP	B-NP	O
DEP	DEP	NNP	I-NP	O
HX	HX	NNP	I-NP	O
FATTY	FATTY	NNP	I-NP	O
LIVER/PANCREATITIS	LIVER/PANCREATITIS	NNP	I-NP	O
OF	OF	IN	B-PP	O
PREGNANCY	PREGNANCY	NNP	B-NP	O
'82	'82	CD	I-NP	O
DEPRESSION	DEPRESSION	NN	I-NP	O
OBESITY	OBESITY	NN	I-NP	O
HYPERLIPIDEMIA	HYPERLIPIDEMIA	NN	I-NP	O
Last	Last	JJ	I-NP	O
echo	echo	NN	I-NP	O
3/14	3/14	CD	B-NP	O
EF	EF	NN	I-NP	O
is	be	VBZ	B-VP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
o/w	o/w	NN	I-NP	O
nl	nl	NN	I-NP	O
.	.	.	O	O

Reports	Report	NNS	B-NP	O
having	have	VBG	B-VP	O
had	have	VBN	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
3	3	CD	B-NP	O
yrs	yr	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
at	at	IN	B-PP	O
?	?	.	O	O

BMD	BMD	NN	B-NP	O
-	-	HYPH	O	O
``	``	``	O	O
normal	normal	JJ	B-ADJP	O
''	''	''	O	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
memory	memory	NN	I-NP	O
.	.	.	O	O

************************	************************	SYM	O	O
MEDS	MEDS	NNP	B-NP	O
:	:	:	O	O
Lantus	Lantus	NNP	B-NP	O
60	60	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Lipitor	Lipitor	NNP	I-NP	O
40MG	40MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Humalog	Humalog	NNP	I-NP	O
12-15	12-15	CD	I-NP	O
SC	SC	NNP	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
Asa	Asa	NNP	B-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
************************	************************	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
************************	************************	SYM	B-NP	O
SH/FH	SH/FH	NN	I-NP	O
:	:	:	O	O
Works	Work	NNS	B-NP	O
at	at	IN	B-PP	O
motor	motor	NN	B-NP	O
veh	veh	NN	I-NP	O
registry	registry	NN	I-NP	O
.	.	.	O	O

Divorced	Divorce	VBN	B-VP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
past	past	JJ	B-NP	O
difficult	difficult	JJ	I-NP	O
social	social	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
children	child	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
source	source	RB	B-ADVP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
helpful	helpful	JJ	I-NP	O
stepdaughter	stepdaughter	NN	I-NP	O
.	.	.	O	O

Nonsmoker	Nonsmoker	NNP	B-NP	O
.	.	.	O	O

Rare	Rare	NN	B-NP	O
EtOH	EtOH	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

************************	************************	SYM	O	O
PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
AT	AT	NN	I-NP	O
DISCHARE	DISCHARE	NN	I-NP	O
T98	T98	NN	I-NP	O
.6	.6	CD	I-NP	O
,	,	,	I-NP	O
130/68	130/68	CD	I-NP	O
,	,	,	I-NP	O
70s	70s	CD	I-NP	O
,	,	,	I-NP	O
94	94	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
AAOx3	AAOx3	NN	B-NP	B-protein
,	,	,	O	O
obese	obese	JJ	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
MMM	MMM	NN	B-NP	O
CHEST	CHEST	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	O
BL	BL	NN	I-NP	O
base	base	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
S1	S1	NN	B-NP	B-protein
S2	S2	NN	I-NP	I-protein
RRR	RRR	NN	I-NP	I-protein
No	No	DT	B-NP	O
MRG	MRG	NN	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
S	S	NN	B-NP	O
,	,	,	O	O
NT/ND	NT/ND	NN	B-NP	B-protein
+	+	SYM	I-NP	O
BS	BS	NN	I-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
+2	+2	CD	B-NP	O
DP	DP	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
warm	warm	JJ	B-NP	O
and	and	CC	I-NP	O
well	well	RB	I-NP	O
perfused	perfuse	VBN	I-NP	O
NEURO	NEURO	NN	I-NP	B-protein
:	:	:	O	O
CNII-XII	CNII-XII	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
grossly	grossly	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

************************	************************	SYM	B-NP	O
STUDIES/DATA	STUDIES/DATA	NN	I-NP	O
:	:	:	O	O
PE-CT	PE-CT	NN	B-NP	O
No	No	DT	B-NP	O
PE	PE	NN	I-NP	O
or	or	CC	I-NP	O
DVT	DVT	NN	I-NP	O
;	;	:	O	O
low	low	JJ	B-NP	O
atten	atten	JJ	I-NP	O
thyroid	thyroid	JJ	I-NP	O
nodules	nodule	NNS	I-NP	O
;	;	:	O	O
asymmetric	asymmetric	JJ	B-NP	O
b/l	b/l	NN	I-NP	O
ground	ground	NN	I-NP	O
glass	glass	NN	I-NP	O
opacity	opacity	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
>	>	SYM	O	O
R	R	NN	B-NP	O
&	&	CC	I-NP	O
dependent	dependent	JJ	I-NP	O
,	,	,	I-NP	O
fatty	fatty	JJ	I-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
at	at	IN	B-PP	O
84	84	CD	B-NP	O
bpm	bpm	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST-T	ST-T	NN	I-NP	O
changes	change	NNS	I-NP	O
except	except	IN	B-PP	O
perhaps	perhaps	RB	B-NP	O
?	?	.	O	O

minor	minor	JJ	B-NP	O
TWI	TWI	NN	I-NP	O
in	in	IN	B-PP	O
AVL	AVL	NN	B-NP	O
;	;	:	O	O
LAE	LAE	NN	B-NP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
moderate	moderate	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
midLAD	midLAD	NN	B-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
Cath	Cath	NN	I-NP	O
:	:	:	O	O
normal	normal	JJ	B-NP	O
right-heart	right-heart	JJ	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
:	:	:	O	O
RA	RA	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
,	,	,	O	O
PCW	PCW	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
,	,	,	O	O
PA	PA	NN	B-NP	O
31/12	31/12	CD	I-NP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
heart-cath	heart-cath	NN	I-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
LM	LM	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

DIffuse	DIffuse	NN	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
prox-mid	prox-mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
with	with	IN	B-PP	O
focal	focal	JJ	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
after	after	IN	B-PP	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
LCx	LCx	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
tubular	tubular	JJ	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
MARG1	MARG1	NN	B-NP	B-protein
,	,	,	O	O
Mid	Mid	NNP	B-NP	O
RCA	RCA	NNP	I-NP	O
diffuse	diffuse	VBP	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

************************	************************	SYM	O	O
HOSPITAL	HOSPITAL	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
AND	AND	CC	O	O
PLAN	PLAN	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
isch	isch	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
pulm	pulm	NN	I-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

Formally	Formally	RB	B-ADJP	O
ruled-out	ruled-out	JJ	I-ADJP	O
Ruled	Rule	VBN	B-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
;	;	:	O	O
pharm	pharm	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
moderate	moderate	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
midLAD	midLAD	NN	B-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
on	on	IN	B-PP	O
7/10	7/10	CD	B-NP	O
showing	show	VBG	I-NP	O
R	R	NN	I-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
LM	LM	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

DIffuse	DIffuse	NN	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
prox-mid	prox-mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
with	with	IN	B-PP	O
focal	focal	JJ	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
after	after	IN	B-PP	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
LCx	LCx	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
tubular	tubular	JJ	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
MARG1	MARG1	NN	B-NP	B-protein
,	,	,	O	O
Mid	Mid	NNP	B-NP	O
RCA	RCA	NNP	I-NP	O
diffuse	diffuse	VBP	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

PCI	PCI	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
with	with	IN	B-PP	O
cypher	cypher	NN	B-NP	O
stenting	stenting	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
procedural	procedural	JJ	I-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

Titrated	Titrate	VBN	B-NP	O
lopressor	lopressor	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ultimately	ultimately	RB	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
atenolol	atenolol	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
from	from	IN	B-PP	O
20	20	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
p	p	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
:	:	:	O	O
currently	currently	RB	B-ADJP	O
euvolemic	euvolemic	JJ	I-ADJP	O
;	;	:	O	O
cont	cont	NN	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
,	,	,	O	O
betablocker	betablocker	NN	B-NP	O
.	.	.	O	O

Echo	Echo	RB	B-ADVP	O
from	from	IN	B-PP	O
9/19	9/19	CD	B-NP	O
shows	show	NNS	I-NP	O
mild	mild	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
EF	EF	NN	I-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	JJ	B-NP	B-protein
r	r	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
:	:	:	O	O
telemetry	telemetry	NN	B-NP	O
,	,	,	O	O
beta	beta	SYM	O	O
blocker	blocker	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
.	.	.	O	O

A1c	A1c	NN	B-NP	O
=	=	SYM	B-VP	O
7.2	7.2	CD	B-NP	O
.	.	.	O	O

Shes	She	NNS	B-NP	O
discharged	discharge	VBN	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
optimized	optimize	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
nutrition	nutrition	NN	B-NP	O
c/s	c/	NNS	I-NP	O
re	re	VBP	B-VP	O
obesity	obesity	NN	B-NP	O
management	management	NN	I-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PPX	PPX	NN	I-NP	O
:	:	:	O	O
lovenox	lovenox	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hosp	hosp	NN	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Code	Code	NNP	I-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Optimize	Optimize	VB	B-VP	O
DM	DM	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Secondary	Secondary	JJ	B-NP	O
prevention	prevention	NN	I-NP	O
on	on	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TAAKE	TAAKE	NN	B-NP	B-protein
,	,	,	O	O
ARMAND	ARMAND	NNP	B-NP	O
BENTON	BENTON	NNP	I-NP	O
CAMERON	CAMERON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SU0	SU0	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/26/06	7/26/06	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

